Exclusive Patent: A Testament to Innovation Our exclusive patent for RiboCeine is a testament to our innovation in Glutathione enhancement
Researchers posit that there are multiple mechanisms through which BPC-157 promotes healing effects when administered to test subjects: BPC-157 is notably thought to work by stimulating the formation of blood vessels, in a process known as angiogenesis
Among these AuNCs, glutathione and albumin protected-AuNCs are excellent candidates for a wide range of biomedical applications due to their biocompatibility, simple preparation in aqueous medium and excellent photoluminescence properties 17,18
Cordycepin has been found to promote insulin synthesis by upregulating the mRNA levels of insulin, Pdx1, and glucose transporter 1 (GLUT1), as well as the protein expression of Pdx1, GLUT1, Akt, and phosphorylated Akt (Sun et al., 2022)
In sports medicine, we are not only asking, Is the weight coming down? We are also asking: Is the patient preserving strength